专利检索 ap:("Baxter International Inc" OR "Baxter Healthcare SA") AND inv:"SUITER, Tobias, M." 第 1 页

1.

发明公开
TREATMENT OF COAGULATION DISEASE BY ADMINISTRATION OF RECOMBINANT VWF 有权
标题翻译：治疗KOAGULATIONSERKRANKUNG在给药重组VWF的

公开(公告)号：EP2717905A1

公开(公告)日：2014-04-16

申请号：EP12728919.7

申请日：2012-06-11

申请人： Baxter International Inc , Baxter Healthcare SA

发明人： SCHEIFLINGER, Friedrich , TURECEK, Peter , EWENSTEIN, Bruce , WONG, Wing, Yen , SUITER, Tobias, M.

IPC分类号： A61K38/36 , A61K38/37 , A61P7/04

CPC分类号： A61K38/36 , A61K38/37 , A61K2300/00

摘要： The present invention provides methods of treating coagulation disease, including hemophilia and von Willebrand disease by administering recombinant von Willebrand Factor alone or in combination with Factor VIII.

摘要翻译： 本发明提供一种治疗凝血病，包括血友病和血管性血友病通过单独或与因子VIII组合管理重组von Willebrand因子的方法。